Scientific Poster Download

The expansion of bioconjugate modalities from conventional ADCs to AOCs, APCs, multi-payload ADCs, and other next-generation therapeutics has introduced unprecedented analytical complexity. Diverse molecular architectures, conjugation strategies, and modality-specific CQAs demand fit-for-purpose analytical approaches that go beyond traditional ADC workflows.

 
To address these challenges, WuXi XDC has established an integrated analytical platform combining orthogonal physicochemical characterization, advanced mass spectrometry, and biofunctional evaluation across the development lifecycle.
 
This poster highlights the platform framework and illustrates how modality-specific analytical strategies enable comprehensive characterization of ADCs and emerging bioconjugates.